Table 1 Sample characteristics of the S-ketamine and the control group
Variables | Categories | S-ketamine group | Control group |
|---|---|---|---|
Group size a | Â | 8 | 8 |
Gender a | Female | 4 | 5 |
Male | 4 | 3 | |
Age b |  | 52.13 ± 13.25 | 54.63 ± 13.23 |
Diagnosis at admission a | Breast cancer | 0 | 3 |
Cancer of unknown primary | 1 | 1 | |
Cervical cancer | 1 | 1 | |
Glioblastoma | 1 | 0 | |
Colorectal cancer | 1 | 0 | |
HIV | 1 | 0 | |
Liver cancer | 0 | 1 | |
Lung cancer | 2 | 0 | |
Ovarian cancer | 0 | 1 | |
Pancreatic cancer | 0 | 1 | |
Prostate cancer | 1 | 0 | |
Length of stay in SPCU (days) b |  | 14.63 ± 7.69 | 13.00 ± 3.42 |
Mode of discharge a | Home | 0 | 4 |
Hospice | 3 | 1 | |
Other clinic | 0 | 2 | |
Died on the ward | 5 | 1 | |
Points of measurement (days) b | T1 | 5.63 ± 2.88 | 3.38 ± 1.06 |
|  | T2 | 8.00 ± 3.70 | 7.50 ± 2.45 |
|  | Z1 | 5.88 ± 2.90 | 3.38 ± 1.06 |
|  | Z2 | 6.88 ± 2.90 | 4.38 ± 1.06 |
STADI anxiety b | T1 | 68.88 ± 11.01 | 57.38 ± 13.38 |
|  | T2 | 55.63 ± 11.73 | 57.50 ± 12.46 |
STADI depression b | T1 | 66.38 ± 10.88 | 59.25 ± 12.51 |
|  | T2 | 57.75 ± 12.75 | 59.00 ± 13.40 |
STADI global b | T1 | 68.38 ± 8.80 | 59.38 ± 13.66 |
|  | T2 | 57.38 ± 11.87 | 59.00 ± 13.27 |
Pain b | Z1 | 3.88 ± 1.64 | 2.88 ± 2.10 |
|  | Z2 | 3.50 ± 1.77 | 2.75 ± 1.67 |
Restlessness/anxiety c | Z1 | 1.00 (1.00–1.75) | 1.00 (0–1.75) |
|  | Z2 | 1.00 (1.00–1.00) | 1.00 (0–1.75) |